BACKGROUND: Arachidonic acid (AA, 20:4n-6), an important second messenger, is released from membrane phospholipid following receptor mediated activation of phospholipase A(2) (PLA(2)). This signaling process can be imaged in brain as a regional brain AA incorporation coefficient K*. HYPOTHESIS: K* will be increased in brain visual areas of subjects submitted to visual stimulation. SUBJECTS AND METHODS: Regional values of K* were measured with positron emission tomography (PET), following the intravenous injection of [1-(11)C]AA, in 16 healthy volunteers subjected to visual stimulation at flash frequencies 2.9 Hz (8 subjects) or 7.8 Hz (8 subjects), compared with the dark (0 Hz) condition. Regional cerebral blood flow (rCBF) was measured with intravenous [(15)O]water under comparable conditions. RESULTS: During flash stimulation at 2.9 Hz or 7.8 Hz vs. 0 Hz, K* was increased significantly by 2.3-8.9% in Brodmann areas 17, 18 and 19, and in additional frontal, parietal and temporal cortical regions. rCBF was increased significantly by 3.1-22%, often in comparable regions. Increments at 7.8 Hz often exceeded those at 2.9 Hz for both K* and rCBF. Decrements in both parameters also were produced, particularly in frontal brain regions. CONCLUSIONS: AA plays a role in signaling processes provoked by visual stimulation, since visual stimulation at flash frequencies of 2.9 and 7.8 Hz compared to 0 Hz modifies both K* for AA and rCBF in visual and related areas of the human brain. The two-stimulus condition paradigm of this study might be used with PET to image effects of other functional activations and of drugs on brain signaling via AA.
BACKGROUND:Arachidonic acid (AA, 20:4n-6), an important second messenger, is released from membrane phospholipid following receptor mediated activation of phospholipase A(2) (PLA(2)). This signaling process can be imaged in brain as a regional brain AA incorporation coefficient K*. HYPOTHESIS: K* will be increased in brain visual areas of subjects submitted to visual stimulation. SUBJECTS AND METHODS: Regional values of K* were measured with positron emission tomography (PET), following the intravenous injection of [1-(11)C]AA, in 16 healthy volunteers subjected to visual stimulation at flash frequencies 2.9 Hz (8 subjects) or 7.8 Hz (8 subjects), compared with the dark (0 Hz) condition. Regional cerebral blood flow (rCBF) was measured with intravenous [(15)O]water under comparable conditions. RESULTS: During flash stimulation at 2.9 Hz or 7.8 Hz vs. 0 Hz, K* was increased significantly by 2.3-8.9% in Brodmann areas 17, 18 and 19, and in additional frontal, parietal and temporal cortical regions. rCBF was increased significantly by 3.1-22%, often in comparable regions. Increments at 7.8 Hz often exceeded those at 2.9 Hz for both K* and rCBF. Decrements in both parameters also were produced, particularly in frontal brain regions. CONCLUSIONS: AA plays a role in signaling processes provoked by visual stimulation, since visual stimulation at flash frequencies of 2.9 and 7.8 Hz compared to 0 Hz modifies both K* for AA and rCBF in visual and related areas of the human brain. The two-stimulus condition paradigm of this study might be used with PET to image effects of other functional activations and of drugs on brain signaling via AA.
Authors: M J Mentis; G E Alexander; C L Grady; B Horwitz; J Krasuski; P Pietrini; T Strassburger; H Hampel; M B Schapiro; S I Rapoport Journal: Neuroimage Date: 1997-02 Impact factor: 6.556
Authors: M C Chang; T Arai; L M Freed; S Wakabayashi; M A Channing; B B Dunn; M G Der; J M Bell; T Sasaki; P Herscovitch; W C Eckelman; S I Rapoport Journal: Brain Res Date: 1997-04-25 Impact factor: 3.252
Authors: G L Shulman; M Corbetta; R L Buckner; M E Raichle; J A Fiez; F M Miezin; S E Petersen Journal: Cereb Cortex Date: 1997 Apr-May Impact factor: 5.357
Authors: Y Bayon; M Hernandez; A Alonso; L Nuñez; J Garcia-Sancho; C Leslie; M Sanchez Crespo; M L Nieto Journal: Biochem J Date: 1997-04-01 Impact factor: 3.857
Authors: M J Mentis; G E Alexander; J Krasuski; P Pietrini; M L Furey; M B Schapiro; S I Rapoport Journal: Am J Psychiatry Date: 1998-06 Impact factor: 18.112
Authors: M J Mentis; B Horwitz; C L Grady; G E Alexander; J W VanMeter; J M Maisog; P Pietrini; M B Schapiro; S I Rapoport Journal: Am J Psychiatry Date: 1996-01 Impact factor: 18.112
Authors: Madhav Thambisetty; Kathy A Gallardo; Jeih-San Liow; Lori L Beason-Held; John C Umhau; Abesh K Bhattacharjee; Margaret Der; Peter Herscovitch; Judith L Rapoport; Stanley I Rapoport Journal: J Cereb Blood Flow Metab Date: 2011-12-14 Impact factor: 6.200
Authors: Francesca Zanderigo; Yeona Kang; Dileep Kumar; Anastasia Nikolopoulou; P David Mozley; Paresh J Kothari; Bin He; David Schlyer; Stanley I Rapoport; Maria A Oquendo; Shankar Vallabhajosula; J John Mann; M Elizabeth Sublette Journal: Synapse Date: 2017-11-27 Impact factor: 2.562
Authors: Lisa Chang; Stanley I Rapoport; Henry N Nguyen; Dede Greenstein; Mei Chen; Mireille Basselin Journal: J Cereb Blood Flow Metab Date: 2009-01-14 Impact factor: 6.200
Authors: Abesh Kumar Bhattacharjee; Lisa Chang; Laura White; Richard P Bazinet; Stanley I Rapoport Journal: Psychopharmacology (Berl) Date: 2008-02-15 Impact factor: 4.530
Authors: Giuseppe Esposito; Giampiero Giovacchini; Jeih-San Liow; Abesh K Bhattacharjee; Dede Greenstein; Mark Schapiro; Mark Hallett; Peter Herscovitch; William C Eckelman; Richard E Carson; Stanley I Rapoport Journal: J Nucl Med Date: 2008-08-14 Impact factor: 10.057
Authors: Abesh K Bhattacharjee; Lisa Chang; Mei Chen; Laura White; Jane M Bell; Richard P Bazinet; Stanley I Rapoport Journal: Int J Neuropsychopharmacol Date: 2008-06-23 Impact factor: 5.176